Insider · CIK 0001697184
Vimal Kavuru
Files at GRCE (Grace Therapeutics, Inc.). First filing -, latest -.
Vimal Kavuru files SEC Form 4 as director at GRCE (Grace Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Vimal Kavuru has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | GRCE Grace Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +12,200 | $0.00 | $0 | 12,200 | 22 d ago |
| Jan 8, 2026 | GRCE Grace Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Jan 12, 2026 |
| May 9, 2025 | GRCE Grace Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | May 13, 2025 |
Questions about Vimal Kavuru
Answered from the filings on this page, as of the latest one.
Is Vimal Kavuru buying or selling?
Vimal Kavuru has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Vimal Kavuru's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vimal Kavuru has 0.
Where does Vimal Kavuru file Form 4?
Vimal Kavuru has filed Form 4 at GRCE (Grace Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.